Ginkgo Bioworks Holdings Inc expected to post a loss of $1.77 a share - Earnings Preview

Ginkgo Bioworks Holdings

21/02/2025 22:10

* Ginkgo Bioworks Holdings Inc  DNA.N   DNA  is expected
to show a
rise in quarterly revenue when it reports  results on February
25 for the period ending December 31 2024
    * The Boston Massachusetts-based  company is expected to
report a
27.9% increase in revenue to $44.464 million from $34.76 million
a year ago, according to the mean estimate from 5 analysts,
based on LSEG data.
    * ​LSEG's mean analyst estimate for Ginkgo Bioworks Holdings
Inc
is for a loss of $1.77 per share. 
    * The current average analyst rating on the shares is "sell"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and 4 "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Ginkgo
Bioworks
Holdings Inc is $8.00​, below​ its last closing price of $10.82.
​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Sep. 30 2024  -2.87       -2.73      -0.94     Beat    65.5
 Jun. 30 2024  -3.20       -3.12      -2.80     Beat    10.3
 Mar. 31 2024  -3.36       -3.33      -3.20     Beat    4​
 Dec. 31 2023  -4.17       -3.87      -4.40     Missed  -13.8
 ​​Sep.        -3.34       -3.43      -6.40     Missed  -86.7
 30 2023                                                
 Jun. 30 2023  -2.99       -3.37      -3.60     Missed  -6.8​
 Mar. 31 2023  -3.44       -3.60      -4.40     Missed  -22.2
 Dec. 31 2022  -8.52       -8.34      -3.60     Beat    56.8
 This summary was machine generated February 21 at 22:10 GMT. 
All figures in US dollars unless otherwise stated. (For
questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)